TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Nov. 06, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 108,550 shares of its common stock to four newly-hired employees, with a grant date of November 4, 2026 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

The inducement grants of restricted stock units covering 58,550 shares of common stock will vest in equal annual installments over four years, subject to each individual's continued service with TELA Bio through the applicable vesting dates. The inducement grant of restricted stock units covering 50,000 shares of common stock will vest 100% on the first anniversary of the Grant Date, subject to the individual's continued service with TELA Bio through the applicable vesting date.